Form 8-K KERYX BIOPHARMACEUTICALS For: Apr 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Keryx Biopharma (KERX) Misses Q1 EPS by 13c
April 28, 2016 8:53 AM EDTKeryx Biopharma (NASDAQ: KERX) reported Q1 EPS of ($0.39), $0.13 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $6.63 million.
Total operating expenses (excluding cost of goods sold and license expenses) for the first quarter ended March 31, 2016... More
